The metabolism of the 2-nitroimidazole hypoxic cell radiosensitizer, misonidazole, has been studied in patients receiving radiotherapy. Results are presented which show that the compound reaches adequate levels in tumour tissue and that, in animal systems, reduction products of the nitro group may also be present. Ah h.p.l.c method is described which has been used to quantify unchanged misonidazole and its nitroimidazole metabolites.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2149433 | PMC |
Publication Analysis
Top Keywords
aspects metabolism
4
metabolism misonidazole
4
misonidazole metabolism
4
metabolism 2-nitroimidazole
4
2-nitroimidazole hypoxic
4
hypoxic cell
4
cell radiosensitizer
4
radiosensitizer misonidazole
4
misonidazole studied
4
studied patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!